Clinical Trials Directory

Trials / Sponsors / Mochida Pharmaceutical Company, Ltd.

Mochida Pharmaceutical Company, Ltd.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study of MD-120 in Patients With Depression
Major Depressive Disorder
Phase 32020-05-18
CompletedEfficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia
Hypertriglyceridemia
Phase 32020-05-09
CompletedLong-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia
Hypertriglyceridemia
Phase 32020-02-14
CompletedEfficacy of MND-2119 in Participants With Hypertriglyceridemia
Hypertriglyceridemia
Phase 32018-10-27
CompletedFebuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout
Hyperuricemia With or Without Gout
Phase 32018-01-09
CompletedStudy of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)
Hyperuricemia With or Without Gout
Phase 12018-01-04
CompletedClinical Pharmacology of FYU-981 (Final Formulation)
Healthy
Phase 12017-11-06
CompletedDrug-drug Interaction Study of FYU-981 and Oxaprozin
Healthy
Phase 12017-11-02
CompletedClinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)
Hepatic Insufficiency, Healthy
Phase 12017-10-06
CompletedUtility of Presepsin in Distinguishing Between Sepsis and SIRS
SIRS, Sepsis
—2014-01-01
CompletedStudy Evaluating Single Ascending Doses of MR1817
Adult
Phase 12010-07-01
CompletedDouble-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (N
Steatohepatitis
Phase 22010-06-01